Several groups have identified several potential biomarkers, including NFBD1, COX2,3 LMP‐14, and MMP19 etc, for predicting NPC recurrence and radio‐chemotherapy resistance.5 However, the mechanisms of NPC progression and recurrence remain unclear. The gene discussed is MDC1; the disease is nasopharyngeal carcinoma.